Business Description
Treatment com AI Inc
NAICS : 923120
SIC : 8699
ISIN : CA8949421017
Description
Treatment com AI Inc operates in the business of providing personalized health care information that is relevant and trustworthy empowering patients to make responsible, informed decisions about their health while improving communications, reducing costs and in-clinic wait times for medical practitioners.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.45 | |||||
| Equity-to-Asset | 0.36 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 4/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 17.6 | |||||
| 3-Year EPS without NRI Growth Rate | 30.2 | |||||
| 3-Year FCF Growth Rate | 45.1 | |||||
| 3-Year Book Growth Rate | 21.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 55.18 | |||||
| 9-Day RSI | 49.08 | |||||
| 14-Day RSI | 47.59 | |||||
| 6-1 Month Momentum % | 16.71 | |||||
| 12-1 Month Momentum % | 165.64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.56 | |||||
| Quick Ratio | 1.56 | |||||
| Cash Ratio | 1.43 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -79.7 | |||||
| Shareholder Yield % | -6.56 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -604.55 | |||||
| ROIC % | -851.24 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 247.32 | |||||
| PB Ratio | 53.77 | |||||
| Price-to-Tangible-Book | 53.77 | |||||
| EV-to-EBIT | -5.21 | |||||
| EV-to-EBITDA | -5.21 | |||||
| EV-to-FCF | -12.25 | |||||
| Price-to-Net-Current-Asset-Value | 53.77 | |||||
| Price-to-Net-Cash | 53.77 | |||||
| Earnings Yield (Greenblatt) % | -19.19 | |||||
| FCF Yield % | -8.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:TREIF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Treatment com AI Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.267 | ||
| Beta | 0.58 | ||
| Volatility % | 69.04 | ||
| 14-Day RSI | 47.59 | ||
| 14-Day ATR ($) | 0.032653 | ||
| 20-Day SMA ($) | 0.540285 | ||
| 12-1 Month Momentum % | 165.64 | ||
| 52-Week Range ($) | 0.0471 - 0.9116 | ||
| Shares Outstanding (Mil) | 48.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Treatment com AI Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Treatment com AI Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Treatment com AI Inc Frequently Asked Questions
What is Treatment com AI Inc(TREIF)'s stock price today?
The current price of TREIF is $0.54. The 52 week high of TREIF is $0.91 and 52 week low is $0.05.
When is next earnings date of Treatment com AI Inc(TREIF)?
The next earnings date of Treatment com AI Inc(TREIF) is .
Does Treatment com AI Inc(TREIF) pay dividends? If so, how much?
Treatment com AI Inc(TREIF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers